Sexy Call Girl Dharmapuri Arshi đ9058824046đ Dharmapuri Escort Service
Â
Survivorship Care and Care Plans: Transforming Challenges into Opportunities
1. Survivorship Care and Care Plans:
Transforming Challenges into Opportunities
Carrie Tompkins Stricker, PhD, CRNP, AOCNÂŽ
Chief Clinical Officer & Co-Founder
Carevive Systems, Inc.
Oncology Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
3. Objectives
⢠To describe the goals, content, and value
of survivorship care plans (SCPs) and
mandates for their delivery
⢠To discuss a step-wise approach to
implementing SCPs in your center
⢠Discuss examples of successful
implementation and outcome evaluation
⢠Describe existing evidence & gaps
4. New Models of Survivorship Care are
Needed
⢠Accountable Care Act (U.S.)
â Call for new care delivery models, population health
â Emphasis on cost as it relates to quality
⢠Institutions need solutions for âtsunami of
demandâ due to aging & improved survival
⢠Current models inadequately address supportive
care needs of cancer survivors
â 70% of survivors in LAF survey said oncologist did offer
support for secondary/supportive care needs
â PCPs report knowledge gaps, & survivors express less
confidence in PCPâs survivorship care abilities
Cox. J.V., 2011; Wolff SN, Hichols C, Ulman D, et al. 2005; Mao, Bowman, Stricker et al., 2009; Kantsiper, M et al.
2009; Nissen, M.J., et al. 2007.
5. Implications of Survivors Unmet
Needs
⢠PATIENT: Negative health outcomes
â Two times greater risk of death in depressed
cancer survivors
â Unmet needs previously described
⢠SYSTEM: Cancer center loss of market
share
â Dissatisfied survivors may seek care elsewhere
â Greater population health costs
â Downstream revenue loss
Mois et al, 2013, Mayer et al., 2011; The Advisory Board Co. Oncology Roundtable, 2014
6. Opportunity
⢠Improve outcomes and QOL for cancer
survivors
⢠Improve the ability of oncologists to
provide care to cancer patients with
greatest need
⢠System ROI:
â Increase new patient volume and associated
revenue
7. Challenge
⢠Oncologists often want to maintain control
& do not coordinate care well
⢠Survivors are in limbo- who does what?
⢠PCPâs are not prepared
7
McCabe, JCO: 2013Grunfeld , JCO; 2006, 2011Cheung, JCO; 2009, 2010;
Del Giudice, JCO; 2009Nekhlyudov, JCO; 2009
8. Primary care providers lack knowledge
about cancer survivorship
⢠Primary care provider (PCP) knowledge of chemotherapy
effects
Cancer Drug % of PCPs that correctly IDâed late effects (n = 1,072)
Cyclophosphamide 15% correctly identified premature menopause; 17% correctly
identified secondary malignancy as late effect
Oxaliplatin 22% correctly identified peripheral neuropathy
Paclitaxel 22% correctly identified peripheral neuropathy
Doxorubicin 55% correctly identified cardiac dysfunction
Only 6% of PCPs were able to correctly identify all late effects
Nekhlyudov L, Aziz N, Lerro CC, Virgo K. Presented June 2, 2012. ASCO Annual Meeting. Abstract 6008] UPDATE
9. From Challenge âŚ
To Opportunity
⢠Oncologists may want to maintain control
& do not coordinate care well
â Engage oncologists in the dialogue and planning
â Develop shared care and care transition models
⢠PCPâs are not prepared
â Provide education, resources, & tools (SCPs)
⢠Survivors are in limbo- who does what?
â Survivorship care plans!!!
9
McCabe, JCO: 2013
Grunfeld , JCO; 2006, 2011
Cheung, JCO; 2009, 2010
Del Giudice, JCO; 2009
Nekhlyudov, JCO; 2009
10. IOM Recommendation #2:
Survivorship care plans
âPatients completing primary treatment should be
provided with a comprehensive:
1. Cancer treatment summary
2. Follow-up (survivorship) care plan
⌠that is clearly and effectively explained
Hewitt, Greenfield, & Stovall (2006). From Cancer Patient to Cancer Survivor: Lost in
Transition. The National Academies Press: Washington, D.C. (p. 151).
11. Purpose of Care Plans
Survivor
PCPOncologist
⢠Enhance communication
⢠Coordinate care
⢠Increase surveillance
⢠Identify and manage long term/late effects
⢠Encourage health monitoring and promotion
13. Survivorship Care Plans (SCPs):
Mandates
⢠Commission on Cancer (CoC)
â 10% of all cancer survivors by January 2015
â 25% by January 2016; 50% by Jan 2017
â 100% by 2019
â Focus on high volume malignancies first
⢠Breast, colorectal, lung, lymphoma, prostate
⢠National Accreditation Program for Breast
Cancer (NABPC)
â 50% of all breast survivors in 2015
â 100% in 2016
â Delivery by 6 months following treatment
14. Commission on Cancer (CoC)
Proposed Standard 3.3 (by 2015)
⢠The cancer care committee develops and implements a
process to disseminate a comprehensive care summary &
follow-up plan to patients with cancer completing cancer
treatment
⢠A survivorship care plan
â Is prepared by the principal provider(s) who coordinated the
oncology treatment
â Is given to the patient on completion of treatment
â Contains a record of care received, important disease
characteristics, and a written follow-up plan
Commission on Cancer, 2011. Cancer Program Standards: Ensuring Patient â Centered Care
15. Readiness survey of CoC member
institutions (early 2014)
⢠Only 37 percent "completely confidentâ in
ability to implement SCP by 2015
⢠Only 21% had developed a SCP process
âŚ. ASCO and the CoC respondâŚ
Mayer DK (2014). Clin J Oncol Nurs 18(6):615-6.
16. SCP Since IOM Report: Barriers
⢠Inconsistent uptake
⢠Time to develop
⢠Lack of reimbursement;
⢠Lack of role clarity regarding who will be completing and
maintaining the information (oncologists, oncology nurse
practitioner/nurse);
⢠Lack of partnership between oncology and primary care
providers to facilitate communication and coordination of care;
⢠Paucity of data about SCPs and improved patient outcomes.
⢠A lack of compatibility of existing templates with EHR and
difficulty in capturing critical information into the SCP.
18. ASCO Clinical Expert Statement on
Survivorship Care Planning
⢠Addresses barriers to SCP Delivery
â Esp. time to complete
⢠Key assumptions re: SCPs
â SCP should
⢠Be simple, clear, understandable
⢠Identify who is responsible for outlined actions
⢠Be given to those NED & completing active Tx
⢠Be shared with patient & PCP and stored in EMR
â Does not replace
⢠Discussions between patient & oncology provider
⢠The medical record
Mayer et al. (2014). J Oncol Pract [Epub ahead of print doi:10.1200/JOP.2014.001321.]
19. Treatment Summary:
ASCO data elements now with less detail
http://www.cancer.net/sites/cancer.net/files/cancer_survivorship.pdf
Principles for inclusion of data elements
Should influence follow-up care
Such data varies between cancer types, requiring
templates to be disease-specific
Enable contact with treating oncology providers as
required for ongoing or future care
Note: Many previously required details did not meet
these criteria (e.g., dose) and were removed
20. âŚBUT more emphasis on a
personalized follow-up plan
⢠Oncology team member contacts
⢠Need for ongoing adjuvant therapy
⢠Intervention to manage ongoing problems from cancer/Tx
⢠Surveillance plan, incl. who responsible*
â Schedule of follow up visits
â Cancer surveillance tests for recurrence
â Cancer screening for early detection of new primaries
â Surveillance for late effects
⢠Possible symptoms of cancer recurrence to report
⢠Late- and/or long-term effects (incl. symptoms to report)
⢠A list of items (e.g. emotional or mental health, parenting,
work/employment, financial issues, and insurance)
⢠Health behaviors and promotion
*who, how often, and where
21. Survivorship Care Plans in context
⢠âItâs not about the paper, Itâs about the
processâ (Melissa Hudson)
⢠âŚ. a survivor care plan is only as good
as the services that it documents.
â these services and resources are what is
so incredibly valuable to cancer survivors1
1Silver, J. Physical Medicine and Rehabilitation 3, 503-506
22. Stakeholder Perspectives
⢠Generally positive endorsement of SCPs
â Survivors
⢠have informational needs that SCPs address
⢠voice widespread support/desire for SCPs
â Primary care providers (PCPs)
⢠express lack of comfort in treating survivors
⢠view SCPs as fostering collaborative care
â Oncology providers
⢠voice support & value as a communication tool
⢠express pragmatic concerns about implementation
â Format, time, personnel, resources
Salz et al., 2012.
23. How to accomplish all this?
⢠Six steps!
a. To develop a programmatic approach to
survivorship care
b. To create treatment summaries and
survivorship care plans
a) Adapted from Cancer Survivorship Training - www.cancersurvivorshiptraining.com; courtesy of Jennifer
Klemp, PhD
b) Adapted from: Advisory Board Company: Oncology Roundtable, 2014
25. Six steps
⢠To create treatment summaries and survivorship
care plans
Adapted from: Advisory Board Company: Oncology Roundtable, 2014
26. Step 1: Start Small
⢠Select target population(s) for pilot
â Start with a population where you have
champions & resources; grow from there
⢠Providers/staff
â Look internally to available resources
â Whoâs available? Whoâs interested?
⢠Convene a multidisciplinary team
â Engage stakeholders, incl. MDs
27. Case Example: Start Small
⢠Breast cancer pilot demonstration project
at UNC
28. Previous UNC SCP Efforts
Presented By Deborah Mayer at 2015 ASCO Annual Meeting
29. Step 2: Choose or Build a
Template
Step 3: Identify data sources
30. Step 2: Choose or build a template
⢠Understanding and weighing options
â Freeware
â Homegrown template(s)
â Commercial software
31. Step 2: Choose or build a template
⢠Understanding and weighing options
â Freeware (Oncolife, LIVESTRONG, Journey
Forward)
⢠Least automation; Greatest staff time
⢠Variable degree of content maintenance
â Homegrown/EMR template(s)
⢠Up-front staff/system investment
⢠Ongoing maintenance
â Commercial software
⢠Up front cost, with potential long term savings
â Automation, tailoring, content maintenance
â Downstream referrals, population management
35. SCP Options: Case Examples
⢠Freeware
â Journey Forward demonstration project* at
UNC over 1 year
⢠n = 75 approached, 34 SCPs delivered
⢠90 minutes to complete surgery + chemo SCP
⢠Homegrown
â UNC
⢠Templates in EPIC developed over years
⢠High resource consumption to develop & maintain
content, challenges with implementation
⢠Commercial
â Hartford Healthcare; 2014 transition from
Equicare to Carevive
*Mayer et al, 2014
36. SCP Options: Case Examples
⢠Freeware
â Journey Forward demonstration project* at
UNC over 1 year
⢠n = 75 approached, 34 SCPs delivered
⢠90 minutes to complete surgery + chemo SCP
⢠Homegrown
â UNC
⢠Templates in EPIC developed over years
⢠High resource consumption to develop & maintain
content, challenges with implementation
⢠Commercial
â Hartford Healthcare; 2014 transition from
Equicare to Carevive
*Mayer et al, 2014
37. EPIC Treatment Summary and
Survivorship Care Plan
Template
Highlights:
⢠EPIC 2014 (enhanced workflow
with EPIC 2015)
⢠@___@ fields will auto-fill
⢠MUST use the problems list
⢠Data can be manually entered
or smart text
⢠Functionality lost for version
2010 users is limited to
discrete data points
⢠Meaningful use:
⢠Printed and/or
⢠Included in MyChart
⢠Templates in prodution:
⢠General (customizable)
⢠Breast
⢠GI
⢠GU
⢠Lung
⢠Adult Survivors of
Childhood Cancers
38.
39.
40. SCP Options: Case Examples
⢠Freeware
â Journey Forward demonstration project* at
UNC over 1 year
⢠n = 75 approached, 34 SCPs delivered
⢠90 minutes to complete surgery + chemo SCP
⢠Homegrown
â UNC
⢠Templates in EPIC developed over years
⢠High resource consumption to develop & maintain
content, challenges with implementation
⢠Commercial
â Hartford Healthcare; 2014 transition from
Equicare to Carevive
43. Step 3: Identify data sources
⢠Survivor identification and tracking
⢠Treatment summary data sources
⢠Care plan content
44. Challenges of SCP delivery:
Data/Content
⢠Populating treatment summary is difficult
and time consuming
â Data in many places, not discrete
45. Step 3: Identify data sources
⢠Treatment summary data sources
â Registry
â EHR
⢠Survivor identification and tracking
â Registry
â EHR
â Clinician dependent
⢠Care plan content
â Guidelines, evidence
â Resources, education
46. SCP Data sources: Case examples
⢠Treatment summary data sources
â EHR: Billings Clinic, Cerner
â Registry: Virtua/Hartford with Carevive
⢠Survivor identification and tracking
â St. Lukeâs MSTI
â Virtua cancer center
⢠Care plan content
â Guidelines, peer-reviewed evidence
â Provider consensus?
â Resources and education
49. Challenges of SCP delivery:
Data/Content
⢠Keeping content up-to-date and evidence
based is resource-intense and difficult
⢠Staff and IT resource utilization
â One center estimates investment of 1 year of
programming time1
â FT survivorship coordinator plus disease-specific
teams required to create & maintain templates2
1Zabora et al. (2015).; 2Rosales et al., 2013
54. Step 4: Assign Staff
Responsibilities
⢠Which personnel for which steps?
â Data analysts/registrars?
â Nurses, nurse navigators
â Billing providers (APPâs, MDs)
⢠Considerations
â Availability, buy-in and sustainability
â Matching skill sets to responsibilities
⢠Operating at top of license/skill set
â Mix of skill sets
58. Step 5: Select a Delivery Method
and Model
⢠Models of care
⢠Approaches to delivery
59. Evolving Survivorship Care Models
Multidisciplinary
â physician, nurse practitioner, psychologist, social worker
Disease-specific
â Breast, prostate
Consultative service
â One-time comprehensive visit
â Treatment Summary and Care Plan
Integrated Care Model
â Usually a NP or APP works within the team, or navigator
â Ongoing care
Shared Care Model
â Collaboration with primary care
60. Step 5: Select a Delivery Method
and Model
⢠Delivery approaches
â Integrated or free-standing/consultative?
â Individual or group?
â One-time or longitudinal?
62. Delivery Models & Outcomes: Case
Examples
⢠Integrated, dual provider model (NP, SW)
â St. Lukeâs MSTI
⢠Group visits
â Duke University
⢠Nurse-led, longitudinal
â Minnesota Oncology
⢠Disease-specific, integrated care model
â Kansas University
64. Survivorship Sustainability
Investment of Resources
ďEstimated salary cost for 90 min SW time,
75 min NP time, and 1 hour of RHIT time
per survivorship clinic patient+ 20%
indirect cost =
$141.73
65. Survivorship Sustainability
Billed to Pt and Insurance
⢠Average Professional/Facility Fee
⢠$272.67
⢠Level 3 or 4 professional fee with
extended time for education and level 3 or
4 facility charge
Reimbursement
$150.69 or 55% of billed amount =
6% Return on Investment
66. Turning challenges into
opportunitiesâŚ
⢠Evidence-based, disease-specific content
continually updated by expert faculty
⢠Personalized and localized content
â to optimize patient satisfaction/engagement
â to improve provider efficiency
⢠Registry data & EMR integration
â to improve efficiency
⢠Reimbursement opportunities maximized
â Visit complexity, coordination of care,
performance-based payments, downstream
revenue
67. Research on Care Plans
Survivor
PCPOncologist
Enhance communication
Coordinate care
Increase surveillance
Identify and manage long term/late effects
Encourage health monitoring and promotion
69. Survivorship Care Plans: Outcomes
⢠Small pilot studies of EOT visits including
SCPs
â Improved adherence to breast/cardiac surveillance1
â High patient satisfaction2,4,5
â Reduced patient concerns/unmet needs3,5
â Improved preparedness for care (survivors)3
EOT = End of treatment
1.Oeffinger, K.C., et al., 2010; 2. SA Crowley et al., 2010; 3. CH Jagielski et al., 2010;
4. Salner et al (2012) . 5. Jefford et al. (2011);
70. Results
⢠Breast survivors used SCP in mean of 6.9
ways
â finding resources, referrals, engaging in health
behaviors
⢠Reported SCPs as useful, informative,
reassuring
⢠Outcomes
â Improved
⢠perceived coordination of care
⢠knowledge of cancer effects and follow up care
72. ButâŚ..
⢠Average time to prepare and deliver SCP
â 2 ½ - 3 hours per patient
âŚ.. AndâŚâŚ.
73. Survivorship Care Plans: RCTs
⢠Grunfeld et al 2012
â n = 408 BrCA survivors
â no improvement in cancer-related distress
⢠Hershman et al 2013 2
â n = 126 BrCA survivors
â No improvement in distress, concerns
â Decreased cancer worry
⢠Brothers et al 2012
â 121 GYN cancer survivors, randomized to SCP vs usual care
â Both groups rated their care highly, with no difference between
arms
⢠Dutch ROGY Trial of an automated SCP in GYN-Onc
â Mixed results re: patient satisfaction with information and care
1. Grunfeld et al., 2011. 2. Hershman et al., 2012. 3. Brothers et al. 2012; 4. Kim A.H. et al., 2012; Nicolaije et al.,
2015.
74. SCP trials to date: Limitations
⢠Sample selection
â Who benefits?
⢠Intervention design
â SCP content, timing
â Process of delivery
⢠Outcome measurement
â Linkage of outcomes assessed to intervention
content
â Relevance of outcomes selected
Stricker, Jacobs, & Palmer (2012)
75. SCP Research:
Other Challenges
⢠Sample issues
â Cross contamination in RCTs
⢠Intervention design
â Concordance of content with standards
â Limited guidance on best processes
⢠Outcome measurement
â Selection of outcome variables
â Limited availability of relevant metrics
Stricker, Jacobs, & Palmer (2012)
76. SCP research:
Solutions and needs
⢠Innovation in intervention
â IT-facilitated solutions
â Personalized SCPs
â Longitudinal approaches
⢠Methodologic approaches
â Metrics for examining concordance
⢠Link content to outcomes
â Outcome metric development
⢠Repositories and knowledge sharing
77. Overall Conclusions
⢠Systematic yet personalized approaches are
needed to improve quality care in survivorship
â Survivorship care plans are a tool to support overall
programmatic approaches
â Infrastructure and technology solutions needed to
maximize reach and impact
⢠Use a stepwise approach to development &
implementation
⢠Additional research needed to document best
models, outcomes, and value
â Contribute to these efforts through careful programmatic
evaluation
78. carevive.com
THANK YOU
â¸To see all the 10 Ways in action, click below:
Request a Demo
â¸More information on the Oncology Care Model
⢠The Oncology Care Model: Ten Strategies for Hospitals
⢠Patient Navigation: 4 Ways to Gear Up for the Oncology Care
Model
⢠The Oncology Care Model (OCM) Model Explained